Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 1 September 2009, doi:10.1136/bmj.b3544
Cite this as: BMJ 2009;339:b3544
Mark Gould
1 London
| The first 150 words of the full text of this article appear below. |
Regulations on controlled drugs that were introduced in the United Kingdom in response to the conviction of the GP Harold Shipman for the murder of 15 patients would make similar crimes harder to commit and would identify a modern day Shipman much sooner, a new report says.
Reviewing the effectiveness of the Controlled Drugs (Supervision of Management and Use) Regulations, introduced in 2007, the Care Quality Commission, the health and social care regulator for England, says that "significant progress" has been made in ensuring the safe storage, use, and disposal of controlled drugs such as diamorphine, which Harold Shipman used to kill as many as 236 patients.
The commission found that most healthcare organisations comply with the regulations and that many of the problems experienced in the first year of the new system have been resolved. It said that healthcare workers are now better trained to deal with concerns about
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?